Which has the lower trailing P/E, HUM or IDXX?

HUM has the lower trailing P/E: HUM trades at 40.76 and IDXX at 41.02. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HUM or IDXX?

Over the past five years, HUM grew revenue faster — HUM at a 11.71% CAGR versus IDXX at 9.24%.

Does HUM or IDXX pay a bigger dividend?

HUM pays a dividend (0.70% yield), while IDXX has no payments in the available dividend history.

Is HUM or IDXX more profitable?

IDXX runs the higher net margin — HUM at 0.82% versus IDXX at 24.63%.

How have HUM and IDXX total returns compared?

Over the past 10 years, HUM delivered 9.18% and IDXX delivered 19.98% annualized total return. Past performance doesn't predict future results.

Humana Inc. (HUM) vs IDEXX Laboratories, Inc. (IDXX)

A side-by-side comparison of Humana Inc. and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

HUM

Humana Inc.

$46.67B

$388.71HealthcareDelayed quote: Jul 28, 2026, 4:01 PM EDT

IDXX

IDEXX Laboratories, Inc.

$44.93B

$569.54HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — HUM vs IDXX

growth of $100 · dividends reinvested · last 30y

HUM +2489.9%IDXX +12340.5%IDXX compounded faster

HUM IDXX

HUM vs IDXX: by the numbers

•HUM is the larger company ($46.67B vs $44.93B market cap).
•HUM trades at the lower trailing earnings multiple (40.76 vs 41.02 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (24.63% vs 0.82% net margin).
•HUM grew revenue faster over the past five years (11.71% vs 9.24% CAGR).
•HUM pays a dividend (0.70% yield), while IDXX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	HUM	IDXX
P/E ratio	40.76	41.02
Forward P/E	42.42	37.97
P/S ratio	0.34	10.09
P/B ratio	2.48	28.84
PEG ratio	N/A	2.31
EV / EBITDA	25.16	29.44
FCF yield	2.77%	2.41%

Profitability

Metric	HUM	IDXX
Gross margin	14.01%	62.05%
Operating margin	1.01%	31.63%
Net margin	0.82%	24.63%
ROE	6.08%	70.38%
ROIC	3.12%	40.27%

Dividends

Metric	HUM	IDXX
Dividend yield	0.70%	N/A
Payout ratio	26.90%	N/A

Growth (annualized)

Metric	HUM	IDXX
Revenue CAGR (5Y)	11.71%	9.24%
EPS CAGR (5Y)	-17.27%	14.07%
FCF CAGR (5Y)	-17.19%	10.13%
Total return CAGR (5Y)	-1.91%	-3.70%

Frequently asked

Which has the lower trailing P/E, HUM or IDXX?: HUM has the lower trailing P/E: HUM trades at 40.76 and IDXX at 41.02. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HUM or IDXX?: Over the past five years, HUM grew revenue faster — HUM at a 11.71% CAGR versus IDXX at 9.24%.
Does HUM or IDXX pay a bigger dividend?: HUM pays a dividend (0.70% yield), while IDXX has no payments in the available dividend history.
Is HUM or IDXX more profitable?: IDXX runs the higher net margin — HUM at 0.82% versus IDXX at 24.63%.
How have HUM and IDXX total returns compared?: Over the past 10 years, HUM delivered 9.18% and IDXX delivered 19.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUM analysis Full IDXX analysis Interactive comparison tool

Dig into the metrics

Humana P/E ratio IDEXX Laboratories P/E ratio Humana dividend yield IDEXX Laboratories dividend yield Humana ROE IDEXX Laboratories ROE Humana operating margin IDEXX Laboratories operating margin Humana revenue growth IDEXX Laboratories revenue growth Humana free cash flow IDEXX Laboratories free cash flow

Humana & IDEXX Laboratories appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.